BR112022020142A2 - Preparação de um 1,3,5-triazinil benzimidazol - Google Patents

Preparação de um 1,3,5-triazinil benzimidazol

Info

Publication number
BR112022020142A2
BR112022020142A2 BR112022020142A BR112022020142A BR112022020142A2 BR 112022020142 A2 BR112022020142 A2 BR 112022020142A2 BR 112022020142 A BR112022020142 A BR 112022020142A BR 112022020142 A BR112022020142 A BR 112022020142A BR 112022020142 A2 BR112022020142 A2 BR 112022020142A2
Authority
BR
Brazil
Prior art keywords
preparation
benzimidazole
triazinyl
triazinyl benzimidazole
triazinil
Prior art date
Application number
BR112022020142A
Other languages
English (en)
Inventor
Duncan David
Original Assignee
Mei Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mei Pharma Inc filed Critical Mei Pharma Inc
Publication of BR112022020142A2 publication Critical patent/BR112022020142A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/18—Carbon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C07D251/44—One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PREPARAÇÃO DE UM 1,3,5-TRIAZINIL BENZIMIDAZOL. É descrita nesse documento a preparação de um 1,3,5-triazinil benzimidazol e intermediários químicos usados no processo sintético.
BR112022020142A 2020-04-07 2021-04-02 Preparação de um 1,3,5-triazinil benzimidazol BR112022020142A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063006564P 2020-04-07 2020-04-07
PCT/US2021/025560 WO2021207024A1 (en) 2020-04-07 2021-04-02 Preparation of a 1,3,5-triazinyl benzimidazole

Publications (1)

Publication Number Publication Date
BR112022020142A2 true BR112022020142A2 (pt) 2022-11-22

Family

ID=78023617

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020142A BR112022020142A2 (pt) 2020-04-07 2021-04-02 Preparação de um 1,3,5-triazinil benzimidazol

Country Status (12)

Country Link
US (1) US20230129089A1 (pt)
EP (1) EP4132533A1 (pt)
JP (1) JP2023521081A (pt)
KR (1) KR20220164788A (pt)
CN (1) CN115697345A (pt)
AU (1) AU2021251071A1 (pt)
BR (1) BR112022020142A2 (pt)
CA (1) CA3179538A1 (pt)
IL (1) IL297040A (pt)
MX (1) MX2022012339A (pt)
TW (1) TW202204349A (pt)
WO (1) WO2021207024A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022197884A1 (en) 2021-03-18 2022-09-22 Teva Pharmaceuticals International Gmbh Solid state forms of zandelisib and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
GEP20125589B (en) * 2008-05-23 2012-07-25 Wyeth Llc TRIAZINE COMPOUNDS AS P13 KINASE AND mTOR INHIBITORS
SG193982A1 (en) * 2011-03-28 2013-11-29 Mei Pharma Inc (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
KR20190058550A (ko) * 2016-09-19 2019-05-29 메이 파마, 아이엔씨. 병용 요법

Also Published As

Publication number Publication date
CN115697345A (zh) 2023-02-03
IL297040A (en) 2022-12-01
EP4132533A1 (en) 2023-02-15
JP2023521081A (ja) 2023-05-23
CA3179538A1 (en) 2021-10-14
WO2021207024A1 (en) 2021-10-14
AU2021251071A1 (en) 2022-10-13
TW202204349A (zh) 2022-02-01
US20230129089A1 (en) 2023-04-27
MX2022012339A (es) 2022-10-27
KR20220164788A (ko) 2022-12-13

Similar Documents

Publication Publication Date Title
BR112017017739A2 (pt) direcionamento de ponto de acesso
PH12018501464A1 (en) A security document comprising a polymer substrate
CL2016000466A1 (es) Compuestos derivados de 2-amino pirimidina sustituida, inhibidores de bmi-1 composicion farmaceutica y uso en el tratamiento del cancer.
AR077833A1 (es) Un metodo para la produccion de un biocida oxidante estable
ECSP21026021A (es) Moduladores de la expresión de pnpla3
BR112022020142A2 (pt) Preparação de um 1,3,5-triazinil benzimidazol
AR116938A1 (es) Proceso para la deshidratación de agua de lodo acuosa
CY1114880T1 (el) Αγωνιστες mglu2
SV2018005702A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
CO2018014030A2 (es) Destrucción de objeto basada en flujo de trabajo
EA201990083A1 (ru) Композиция для ухода за полостью рта
SV2018005701A (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cancer
JP2019136778A5 (pt)
CO2020008769A2 (es) Moduladores de la expresión dnm2
CR7795A (es) Tetralinos e indanes sustitutos
BR112017012454A2 (pt) telha que contém fibra, material de moldagem para produzir telha que contém fibra e processo para produzir a mesma
JPWO2021200807A5 (pt)
EA201892469A1 (ru) Опорная шайба
EA202192101A1 (ru) Соединения и их применение
UA145104U (uk) Застосування монтелукасту як засобу фригопротекторної та протисудомної дії
EA202090734A1 (ru) Применение диамина для увеличения механической прочности волос и средство для ухода за волосами, его содержащее
JP2022117760A5 (pt)
JP2022079830A5 (pt)
AR123432A1 (es) Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
BR112018076636A2 (pt) mistura líquida, processo para preparação de uma mistura líquida, composição e processo de tratamento cosmético

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing